19 June 2013
Keywords: good, outlook, israel, teva, pharmaceuticals, been, given
Article | 26 July 1993
Israel's Teva Pharmaceuticals has been given an outperform rating by
analysts David Saks of Gruntal & Co in the USA. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 July 1993
19 July 1993
18 June 2013
© 2013 thepharmaletter.com